health_and_safety
Health
Phase 3 mRNA Universal Oncology Trial Demonstrates 96% Targeted Cell Neutralization
A fictional Phase 3 mRNA trial reports 96% targeted cell neutralization. We explain what that term means, what it does not, and the limits of the study.